Administrative Core
Administrative Core
批准号:
10526102
负责人:
James R. Heath
金额:
$24.66万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-22 至 2027-08-31
关键词:
Administrative CoordinationAdvocateAwarenessBiologicalCancer BiologyClinicClinicalClinical OncologyCombination immunotherapyCombined Modality TherapyCommunicationCommunitiesConflict (Psychology)CustomCutaneous MelanomaDataEducationEducational process of instructingEngineeringEnvironmentEvaluationFacultyFeedbackFundingFuture TeacherGoalsImmunotherapyInfrastructureInstitutionIntellectual PropertyLearningLogisticsMalignant NeoplasmsMentorsMonitorPatientsPersonsPilot ProjectsProcessProtocols documentationReagentResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResource SharingSTEM fieldScheduleScientistSeedsSelf-ExaminationSeriesSolid NeoplasmSpecimenStructureStudentsSystems BiologyTalentsThinkingTimeTissuesTraining SupportTranslationsUnderrepresented MinorityUnderrepresented Populationsbiobankcollaborative environmentdesignfaculty researchflexibilityinhibitormeetingsmouse modelmultiple omicsoutreachoutreach programprogramsspatiotemporaltargeted treatmentteachertooltranslational goaltumor
中文摘要
管理和协调核心
项目摘要
拟议的U54时空肿瘤分析中心的行政和协调核心
引导序贯靶向抑制物:免疫治疗组合(ST-Analytics旨在
促进和支持ISB、耶鲁和加州大学洛杉矶分校的科学家以及我们的
外展计划、我们的试点项目和跨联盟项目。ST-Analytics的科学计划
旨在解决如何最好地利用免疫疗法/靶向疗法序贯组合来治疗
实体瘤的临床治疗,从转移性皮肤黑色素瘤开始。这需要
汇聚了临床、生物、物理、工程和计算的跨学科组合
科学家以及最先进的多组学分析工具、同基因小鼠模型和丰富的生物信息库
高度相关的患者组织。实现ST-Analytics的科学目标需要响应的管理
(I)促进和实现ST-Analytics之间的有效沟通和资源共享的结构
研究人员和更广泛的癌症系统生物学联盟(CSBC),(Ii)建立了高度互动的
ST-Analytics研究人员可以成为彼此的好学生和好老师的环境,(Iii)促进
及时实现方案的具体目标,(4)在科学和
后勤冲突出现,(V)通过各种机制促进我们科学工作者的多样性,包括
但不限于种子项目资金、外展计划和提高对这些关键问题的认识
我们的远程和面对面会议,以及(Vi)监测科学的完整性和稳健性
设计。ST-Analytics管理核心应该促进数据、新想法、实验的自由流动
两个机构之间的协议、定制试剂和生物检疫。它应该建立起工作
与其他资助中心的关系。它应该促进临床或商业翻译和教育
外展。它应该鼓励灵活思维,以应对新的机遇或意想不到的障碍。
最后,它应该促进健康的自我评估环境。
英文摘要
Administration and Coordination Core
Project Summary
The administrative and coordination core of the proposed U54 Center for Spatiotemporal Tumor Analytics for
Guiding Sequential Targeted Inhibitor : Immunotherapy Combinations (ST-Analytics is designed to
promote and support the integrated research efforts of scientists from the ISB, Yale, and UCLA, as well as our
Outreach program, our Pilot Projects and Cross-Consortium Projects. The scientific programs of ST-Analytics
are designed to resolve how to best harness immunotherapy/targeted therapy sequential combinations for the
treatment of solid tumors in the clinic, starting with a focus on metastatic cutaneous melanoma. This requires
bringing together a cross-disciplinary mix of clinical, biological, physical, engineering, and computational
scientists, as well as state-of-the-art, multiomic profiling tools, syngeneic mouse models, and a rich bio-repository
of highly relevant patient tissues. Meeting the ST-Analytics scientific goals requires a responsive administrative
structure that (i) promotes and enables effective communication and resource sharing between the ST-Analytics
researchers and the broader Cancer Systems Biology Consortium (CSBC), (ii) establishes a highly interactive
environment wherein ST-Analytics researchers can be good students and teachers of each other, (iii) promotes
achieving the program specific aims in a timely manner, (iv) intervenes as early as possible when scientific and
logistic conflicts arise, (v) promotes diversity in our scientific workforce through various mechanisms, including
but not limited to seed project funding, outreach programs, and raising awareness of these critical issues during
our remote and in-person meetings, and (vi) monitoring the scientific integrity and robustness of scientific
designs. The ST-Analytics administrative CORE should facilitate the free flow of data, new ideas, experimental
protocols, customized reagents, and biospecimens between the institutions. It should establish working
relationships with other funded centers. It should facilitate clinical or commercial translation and educational
outreach. It should encourage flexible thinking in anticipation of new opportunities or unexpected roadblocks.
Finally, it should facilitate a healthy environment of self-evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
-
批准号:10708901
-
项目类别:
-
资助金额:$254.9万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
-
批准号:10907268
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
-
批准号:10526101
-
项目类别:
-
资助金额:$270.26万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
-
批准号:10526103
-
项目类别:
-
资助金额:$82.5万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Administrative Core
-
批准号:10708920
-
项目类别:
-
资助金额:$37.85万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
-
批准号:10708924
-
项目类别:
-
资助金额:$75.24万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Data-driven Patient-Specific Agent Based Models of Metastatic Melanoma for Immunotherapy Response Prediction
-
批准号:10831325
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
-
批准号:10297588
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2021
-
负责人:James R. Heath
-
依托单位:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
-
批准号:10489832
-
项目类别:
-
资助金额:$54.79万
-
财政年份:2021
-
负责人:James R. Heath
-
依托单位:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
-
批准号:10673935
-
项目类别:
-
资助金额:$52.8万
-
财政年份:2021
-
负责人:James R. Heath
-
依托单位:
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
-
批准号:9618374
-
项目类别:
-
资助金额:$54.35万
-
财政年份:2017
-
负责人:James R. Heath
-
依托单位:
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
-
批准号:10249961
-
项目类别:
-
资助金额:$67.07万
-
财政年份:2017
-
负责人:James R. Heath
-
依托单位:
Steady states and cellular transitions associated with carcinogenesis and tumor progression
-
批准号:9355497
-
项目类别:
-
资助金额:$10.07万
-
财政年份:2017
-
负责人:James R. Heath
-
依托单位:
Nanosystems Biology Cancer Center
-
批准号:9132733
-
项目类别:
-
资助金额:$244.66万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Crump Preclinical Imaging Core
-
批准号:8962028
-
项目类别:
-
资助金额:$14.21万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K
-
批准号:8962031
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
-
批准号:8962032
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Nanosystems Biology Cancer Center
-
批准号:8962026
-
项目类别:
-
资助金额:$232.5万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Administrative Core
-
批准号:8962034
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Nanosystems Biology Cancer Center
-
批准号:9342707
-
项目类别:
-
资助金额:$100.94万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
海外基金